These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8960364)

  • 1. Expression of Oct-4 during differentiation of murine F9 cells.
    Wang L; Schultz GA
    Biochem Cell Biol; 1996; 74(4):579-84. PubMed ID: 8960364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of ribosomal RNA gene transcription during retinoic acid-induced differentiation of mouse teratocarcinoma cells.
    Datta PK; Budhiraja S; Reichel RR; Jacob ST
    Exp Cell Res; 1997 Feb; 231(1):198-205. PubMed ID: 9056427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Oct-4 gene expression during differentiation of EC cells.
    Schoorlemmer J; Jonk L; Sanbing S; van Puijenbroek A; Feijen A; Kruijer W
    Mol Biol Rep; 1995; 21(3):129-40. PubMed ID: 8832901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The octamer motif present in the Rex-1 promoter binds Oct-1 and Oct-3 expressed by EC cells and ES cells.
    Rosfjord E; Rizzino A
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1795-802. PubMed ID: 7945330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid induces parietal endoderm but not primitive endoderm and visceral endoderm differentiation in F9 teratocarcinoma stem cells with a targeted deletion of the Rex-1 (Zfp-42) gene.
    Thompson JR; Gudas LJ
    Mol Cell Endocrinol; 2002 Sep; 195(1-2):119-33. PubMed ID: 12354678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extinction of Oct-3/4 gene expression in embryonal carcinoma x fibroblast somatic cell hybrids is accompanied by changes in the methylation status, chromatin structure, and transcriptional activity of the Oct-3/4 upstream region.
    Ben-Shushan E; Pikarsky E; Klar A; Bergman Y
    Mol Cell Biol; 1993 Feb; 13(2):891-901. PubMed ID: 7678695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the Oct-4 gene by nuclear receptors.
    Sylvester I; Schöler HR
    Nucleic Acids Res; 1994 Mar; 22(6):901-11. PubMed ID: 8152920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of genes for insulin and insulin-like growth factors and receptors in early postimplantation mouse embryos and embryonal carcinoma cells.
    Telford NA; Hogan A; Franz CR; Schultz GA
    Mol Reprod Dev; 1990 Oct; 27(2):81-92. PubMed ID: 1701096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of Oct-4 during embryonic cell differentiation correlates with the appearance of TRIF, a transiently induced DNA-binding factor.
    Fuhrmann G; Sylvester I; Schöler HR
    Cell Mol Biol (Noisy-le-grand); 1999 Jul; 45(5):717-24. PubMed ID: 10512201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain.
    Brehm A; Ohbo K; Schöler H
    Mol Cell Biol; 1997 Jan; 17(1):154-62. PubMed ID: 8972195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human.
    Hart AH; Hartley L; Ibrahim M; Robb L
    Dev Dyn; 2004 May; 230(1):187-98. PubMed ID: 15108323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells.
    Okamoto K; Okazawa H; Okuda A; Sakai M; Muramatsu M; Hamada H
    Cell; 1990 Feb; 60(3):461-72. PubMed ID: 1967980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo.
    Rosner MH; Vigano MA; Ozato K; Timmons PM; Poirier F; Rigby PW; Staudt LM
    Nature; 1990 Jun; 345(6277):686-92. PubMed ID: 1972777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of SPARC is correlated with altered morphologies in transfected F9 embryonal carcinoma cells.
    Everitt EA; Sage EH
    Exp Cell Res; 1992 Mar; 199(1):134-46. PubMed ID: 1310471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy of SF1 and RAR in activation of Oct-3/4 promoter.
    Barnea E; Bergman Y
    J Biol Chem; 2000 Mar; 275(9):6608-19. PubMed ID: 10692469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2.
    Botquin V; Hess H; Fuhrmann G; Anastassiadis C; Gross MK; Vriend G; Schöler HR
    Genes Dev; 1998 Jul; 12(13):2073-90. PubMed ID: 9649510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of alpha 6/beta 1 integrin expression during differentiation of F9 murine embryonal carcinoma cells to parietal endoderm.
    Morini M; Piccini D; Barbieri O; Astigiano S
    Exp Cell Res; 1997 May; 232(2):304-12. PubMed ID: 9168806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The octamer binding factor Oct6: cDNA cloning and expression in early embryonic cells.
    Meijer D; Graus A; Kraay R; Langeveld A; Mulder MP; Grosveld G
    Nucleic Acids Res; 1990 Dec; 18(24):7357-65. PubMed ID: 1979677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of human embryonal carcinoma stem cells by immunomagnetic sorting.
    Przyborski SA
    Stem Cells; 2001; 19(6):500-4. PubMed ID: 11713341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation.
    Palmieri SL; Peter W; Hess H; Schöler HR
    Dev Biol; 1994 Nov; 166(1):259-67. PubMed ID: 7958450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.